Brontictuzumab: Ph Ib started

OncoMed began an open-label, U.S. Phase Ib trial to evaluate brontictuzumab plus Lonsurf trifluridine/tipiracil. A dose-escalation portion will enroll about 24 patients to determine the dose for the d...